Archive

Learn how long-acting injectable PrEP can transform HIV responses in South Africa while bridging treatment access gaps.

Discover how digitisation drives Netcare’s growth, reflected in increased revenue and dividends despite economic challenges.

South Africa doubles its pledge to the Global Fund replenishment, aiming to combat HIV, TB, and malaria effectively.

Eli Lilly hits $1 trillion valuation, marking a historic milestone in the pharmaceutical industry with successful weight-loss drugs.

The UK Covid-19 Inquiry reveals that 23,000 preventable deaths resulted from lockdown delays and a toxic government culture.

Explore the challenges and fiscal realities of NHI South Africa in the context of healthcare reform and political ideology.

Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.

China’s HIV prevention funding of $3.49 million aims to support South Africa’s young people and drug users for better health outcomes.

A pioneering public-private healthcare partnership cuts backlogs and addresses inefficiencies in surgery and patient care in KZN.

Life Healthcare share price falls 9% due to R2.9bn adjustment linked to the Piramal liability affecting investor sentiment.

Delve into the dramatic rise of childhood hypertension and its implications for future health outcomes for young people globally.